Stoke Therapeutics, Inc. (STOK): SCHEDULE 13D/A filed Jun 6, 2025

Form type

SCHEDULE 13D/A

Filing date

Jun 6, 2025

Accession number

0001123292-25-000272

Filer

Stoke Therapeutics, Inc. (CIK 1623526)